Search research articles
Contact Us
Filters
Showing results (21-30 of 23) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 23 results.
Molecular Cancer Therapeutics
|
February 4, 2015
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments
Frank Loganzo, Xingzhi Tan, Matthew Sung, et al.
Endocrinology
|
January 1, 2004
A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis
Qiu Guo, Soumya P Sahoo, Pei-Ran Wang, et al.
Molecular Cancer Therapeutics
|
May 14, 2025
A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint Therapies
Keith Abayasiriwardana, Lei Wu, Hanane Laklai, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 23) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 23 results.
Molecular Cancer Therapeutics
|
February 4, 2015
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments
Frank Loganzo, Xingzhi Tan, Matthew Sung, et al.
Endocrinology
|
January 1, 2004
A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis
Qiu Guo, Soumya P Sahoo, Pei-Ran Wang, et al.
Molecular Cancer Therapeutics
|
May 14, 2025
A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint Therapies
Keith Abayasiriwardana, Lei Wu, Hanane Laklai, et al.
Page
of 3